Abstract
Seizures after cardiopulmonary arrest are a common problem in the intensive care unit, occurring in as many as one-third of these patients during their hospitalization. The etiology, treatment, and prognostic importance of seizures in this setting have not been well-delineated in the literature. Whether seizures exacerbate global hypoxic-ischemic brain injury in humans remains unclear, which raises uncertainty about how aggressively they should be treated. Some pathological data suggest that anoxic brain injury is worsened by generalized tonic-clonic (GTC) status epilepticus (SE). Especially when the prognosis remains uncertain, GTC SE should be treated in the conventional manner. Partial seizures and simple myoclonus are unlikely to exacerbate neuronal damage, and treatment probably should be reserved for seizures that are traumatic to family members or interfere with mechanical ventilation. Status myoclonus (SM) in hypoxic-ischemic coma is particularly troublesome because it can be highly refractory to conventional anticonvulsants and appears to portend an extremely poor prognosis, regardless of its management. Case series that report 100% mortality or vegetative state from this condition have involved only highly selected patient populations. Several cases have been reported of patients with good neurological outcomes despite SM in postanoxic coma. The most prudent course of action is to continue intensive management of patients with SM—including anticonvulsant therapy—and to rely on more precise means of prognostication (clinical exam, electroencephalography, and somatosensory evoked potential) to inform the decision to withdraw supportive care. The decision to use anesthetic agents and paralytics in this setting must be individualized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Krumholz A, Stern BJ, Weiss HD. Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclonus. Neurology 1988;38:401–405.
Snyder BD, Ramirez-Lassepas M, Lippert DM. Neurologic status and prognosis after cardiopulmonary arrest. I. A retrospective study. Neurology 1977;27:807–811.
Snyder BD, Hauser WA, Loewenson RB, Leppik IE, Ramirez-Lassepas M, Gumnit RJ. Neurologic prognosis after cardiopulmonary arrest. III. Seizure activity. Neurology 1980;30:1292–1297.
Levy DE, Caronna JJ, Singer BH, Lapinski RH, Frydman H, Plum F. Predicting outcome from hypoxic-ischemic coma. JAMA 1985;253:1420–1426.
Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 1963;86:111–136.
Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, et al. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 2001;292:1543–1546.
Meldrum BS. Epileptic brain damage: a consequence and cause of seizures. Neuropathol Appl Neurobiol 1997; 23:185–202.
Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451:205–212.
Fariello RG, Golden GT, Smith GG, Reyes PF. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res 1989;3:206–213.
Norman RM. The neuropathology of status epilepticus. Med Sci Law 1964;4:46–51.
Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates: ischemic cell change and its relation to ictal physiological events. Arch Neurol 1973;28:10–17.
O’Connell BK, Towfighi J, Kofke WA, Hawkins RA. Neuronal lesions in mercaptopropionic acid-induced status epilepticus. Acta Neuropathol 1988;77:47–54.
Nevander G, Ingvar M, Auer R, Siesjö BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol 1985;18:281–290.
Brierley JB. Cerebral hypoxia. In: Blackwood W, Corsellis JAN, eds. Greenfield’s Neuropathology. Edinburgh: Edward Arnold; 1976:43–85.
Young RSK, During MJ, Aquila WJ, Tendler D, Ley E. Hypoxia increases extracellular concentrations of excitatory and inhibitory neurotransmitters in subsequently induced seizure: in vivo microdialysis study in the rabbit. Exp Neurol 1992;117:204–209.
Cataltepe O, Vannucci RC, Heitjan DF, Towfighi J. Effect of status epilepticus on hypoxic-ischemic brain damage in the immature rat. Pediatr Res 1995;38:251–257.
Hayakawa T, Higuchi Y, Nigami H, Hattori H. Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsant effect. Eur J Pharmacol 1994;257:131–136.
Towfighi J, Housman C, Mauger D, Vannucci RC. Effect of seizures on cerebral hypoxic-ischemic lesions in immature rats. Dev Brain Res 1999;113:83–95.
Wirrell EC, Armstrong EA, Osman LD, Yager JY. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res 2001;50:445–454.
Young GB, Gilbert JJ, Zochodne DW. The significance of myoclonic status epilepticus in postanoxic coma. Neurology 1990;40:1843–1848.
Wijdicks EFM, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol 1994;35:239–243.
Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol 1988;45:781–784.
Guilleminault C, Tharp BR, Cousin D. HVA and 5-HIAA CSF measurements and 5-HTP trials in some patients with involuntary movements. J Neurol Sci 1973;18:435–441.
Chadwick D, Hallet M, Harris R, Jenner P, Reynolds EH, Marsden CD. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-HTP, tryptophan with monoamine oxidase inhibitor, and clonazepam. Brain 1977;100:455–487.
Jaw SP, Hussong MJ, Matsumoto RR, Truong DD. Involvement of 5-HT2 receptors in posthypoxic stimulus-sensitive myoclonus in rats. Pharmacol Biochem Behav 1994;49:129–131.
Pappert EJ, Goetz CG, Vu TQ, Ling ZD, Leurgans S, Raman R, Carvey PM. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology 1999;52:16–21.
Truong DD, Matsumoto RR, Schwartz PH, Hussong MJ, Wasterlain CG. Novel rat cardiac arrest model of posthypoxic myoclonus. Movement Disord 1994;9:201–206.
De Lean J, Richardson JC, Hornykiewicz O. Beneficial effect of serotonin precursors in postanoxic action myoclonus. Neurology 1976;26:863–868.
Gimenez-Roldan S, Mateo D, Muradas V, De Yeben JG. Clinical, biochemical, and pharmacologic observation in a patient with postasphyxial myoclonus: association with serotonin hyperactivity. Clin Neuropharmacol 1998; 11: 151–160.
Jumao-as A, Brenner RP. Myoclonic status epilepticus: a clinical and electroencephalographic study. Neurology 1990;40:1199–1202.
Niedermeyer E, Bauer G, Burnite R, Reichenbach D. Selective stimulus-sensitive myoclonus in acute cerebral anoxia. Arch Neurol 1977;34:365–368.
Van Cott AC, Blatt I, Brenner RP. Stimulus-sensitive seizures in postanoxic coma. Epilepsia 1996; 37:868–874.
Wolf P. Periodic synchronous and stereotyped myoclonus with postanoxic coma. J Neurol 1977;215: 39–47.
Kanemoto K, Ozawa K. A case of post-anoxic encephalopathy with initial massive myoclonic status followed by alternating Jacksonian seizures. Seizure 2000;9:352–355.
Wijdicks EFM, Young GB. Myoclonus status in comatose patients after cardiac arrest. Lancet 1994; 343:1642,1643.
Arnoldus EPJ, Lammers GJ. Postanoxic coma: good recovery despite myoclonus status. Ann Neurol 1995; 38:697,698.
Hanakawa T, Hashimoto S, Iga K, Segawa Y, Shibasaki H. Carotid brainstem myoclonus after hypoxic brain damage. J Neurol Neurosurg Psychiatry 2000;69:672–674.
Hallett M. The pathophysiology of myoclonus. Trends Neurosci 1987;10:69–73.
Harper SJ, Wilkes RG. Posthypoxic myoclonus (the Lance-Adams syndrome) in the intensive care unit. Anaesthesia 1991;46:199–201.
Werhahn KJ, Brown P, Thompson PD, Marsden CD. The clinical features and prognosis of chronic posthypoxic myoclonus. Movement Disord 1997;12:216–220.
Hallett M, Chadwick D, Adam J, Marsden CD. Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. J Neurol Neurosurg Psychiatry 1977;40:253–264.
Brown P, Thompson PD, Rothwell JC, Day BL, Marsden CD. A case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus. Movement Disord 1991;6: 139–144.
Witte OW, Niedermeyer E, Arendt G, Freund HJ. Post-hypoxic action (intention) myoclonus: a clinico-electroencephalographic study. J Neurol 1988;235:214–218.
Lance JW, Adams RD. Negative myoclonus in posthypoxic patients: historical note. Movement Disord 2001; 16:162–163.
Fahn S. Posthypoxic action myoclonus: literature review update. Adv Neurol 1986;43:157–169.
Varelas PN, Spanaki MV, Hacein-Bey L, Hether T, Terranova B. Emergent EEG: indications and diagnostic yield. Neurology 2003;61:702–704.
Beydoun A, Yen CE, Drury I. Variance of interburst intervals in burst suppression. Electroencephalogr Clin Neurophysiol 1991;79:435–439.
Chen R, Bolton CF, Young GB. Prediction of outcome in patients with anoxic coma: a clinical and electro-physiologic study. Crit Care Med 1996;24:672–678.
Binnie CD, Prior PF, Lloyd DSL, Scott DF, Margison JH. Electroencephalographic prediction of fatal anoxic brain damage after resuscitation for cardiac arrest. Br Med J 1970;4:265–268.
Møller M, Holm B, Sindrup E, Lyager Nielsen B. Electroencephalographic prediction of anoxic brain damage after resuscitation from cardiac arrest in patients with acute myocardial infarction. Acta Med Scand 1978; 203: 31–37.
Zandbergen EGJ, de Haan RJ, Stoutenbeek CP, Koelman JHTM, Hijdra A. Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet 1998;352:1808–1812.
Ahmed I. Use of somatosensory evoked responses in the prediction of outcome from coma. Clin Electroencephalogr 1988;19:78–86.
Bassetti C, Bomio F, Mathis J, Hess CW. Early prognosis in coma after cardiac arrest: a prospective clinical, electrophysiological, and biochemical study of 60 patients. J Neurol Neurosurg Psychiatry 1996;61: 610–615.
Brunko E, Zegers de Beyl D. Prognostic value of early cortical somatosensory evoked potentials after resuscitation from cardiac arrest. Electroencephalogr Clin Neurophysiol 1987;66:14–24.
Kano T, Shimoda O, Morioka T, Yagishita Y, Hashiguchi A. Evaluation of the central nervous function in resuscitated comatose patients by multilevel evoked potentials. Resuscitation 1992;23:235–248.
Rothstein TL, Thomas EM, Sumi SM. Predicting outcome in hypoxic-ischemic coma. A prospective clinical and electrophysiologic study. Electoencephalogr Clin Neurophysiol 1991;79:101–107.
Walser H, Mattle H, Keller HM, Janzer R. Early cortical median nerve somatosensory evoked potentials. Prognostic value in anoxic coma. Arch Neurol 1985;42:32–38.
Madl C, Kramer L, Yeganehfar W. Detection of nontraumatic comatose patients with no benefit of intensive care treatment by recording of sensory evoked potentials. Arch Neurol 1996;53:512–516.
Torbey MT, Selim M, Knorr J, Bigelow C, Recht L. Quantitative analysis of the loss of distinction between gray and white matter in comatose patients after cardiac arrest. Stroke 2000;31:2163–2167.
Arbelaez A, Castillo M, Mukherji SK. Diffusion-weighted MR imaging of global cerebral anoxia. AJNR Am J Neuroradiol 1999;20:999–1007.
Kim JA, Chung JI, Yoon PH, Kim DI, Chung TS, Kim EJ, Jeong EK. Transient MR signal changes in patients with generalized tonic-clonic seizure or status epilepticus: periictal diffusion-weighted imaging. AJNR Am J Neuroradiol 2001;22:1149–1160.
Ye JH, Ren J, Krnjevic K, Liu PL, McArdle JJ. Cocaine and lidocaine have additive inhibitory effects on GABA. A current of acutely dissociated hippocampal pyramidal cells. Brain Res 1999;821:26–32.
Barat SA, Abdel-Rahman MS. Decreased cocaine-and lidocaine-induced seizure response by dextromethorphan and DNQX in rat. Brain Res 1997;756:179–183.
DeToledo JC. Lidocaine and seizures. Ther Drug Monit 2000;22:320–322.
Kerns W, English B, Ford M. Propafenone overdose. Ann Emerg Med 1994;81:35–39.
Caramelli P, Mutarelli EG, Caramelli B, Tranchesi B, Pileggi F, Schaff M. Neurological complications after thrombolytic treatment for acute myocardial infarction: emphasis on unprecedented manifestations. Acta Neurol Scand 1992;85:331–333.
Cooling DS. Theophylline toxicity. J Emerg Med 1993;11:415–425.
Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995;333: 1267–1272.
Koppel BS, Samkoff L, Daras M. Relation of cocaine use to seizures and epilepsy. Epilepsia 1996; 37:875–878.
Goh WC, Heath PD, Ellis SJ, Oakley PA. Neurological outcome prediction in a cardiorespiratory arrest survivor. Br J Anaesth 2002;88:719–722.
Brain Resuscitation Clinical Trial I Study Group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986;314:397–403.
Kanthasamy AG, Vu TQ, Yun RJ, Truong DD. Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus. Eur J Pharmacol 1996;297:219–224.
Fahn S. Post-anoxic action myoclonus: improvement with valproic acid. N Engl J Med 1978;299: 313–314.
Hirose G, Singer P, Bass N. Successful treatment of posthypoxic action myoclonus with carbamazepine. JAMA 1971;218:1432,1433.
Coletti A, Mandelli A, Minoli G, Tredici G. Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs. J Neurol 1980;223:67–70.
Beretta E, Regli F, de Crousaz G, Steck AJ. Postanoxic myoclonus: treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor. J Neurol 1981;225:57–62.
Krauss GL, Bergin A, Kramer RE, Cho YW, Reich SG. Suppression of post-hypoxic and postencephalitic myoclonus with levetiracetam. Neurology 2001;56:411,412.
Willoughby JO, Leach BG. Relation of neurological findings after cardiac arrest to outcome. Br Med J 1974;3:437–439.
Edgren E, Hedstrand U, Kelsey S, Sutton-Tyrrell K, Safar P, and BRCT I Study Group. Assessment of neurological prognosis in comatose survivors of cardiac arrest. Lancet 1994;343:1055–1059.
Longstreth WT, Diehr P, Inui TS. Prediction of awakening after out-of-hospital cardiac arrest. N Engl J Med 1983;308:1378–1382.
Berek K, Schinnerl A, Traweger C, Lechleitner P, Baubin M, Aichner F. The prognostic significance of coma-rating, duration of anoxia and cardiopulmonary resuscitation in out-of-hospital cardiac arrest. J Neurol 1997;244:556–561.
Madl C, Grimm G, Kramer L, Yeganehfar W, Sterz F, Schneider B, et al. Early prediction of individual outcome after cardiopulmonary resuscitation. Lancet 1993;341:855–858.
So HY, Buckley TA, Oh TE. Factors affecting outcome following cardiopulmonary resuscitation. Anaesth Intens Care 1994;22:647–658.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Koenig, M.A., Geocadin, R. (2005). Global Hypoxia-Ischemia and Critical Care Seizures. In: Varelas, P.N. (eds) Seizures in Critical Care. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59259-841-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-59259-841-0_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-342-8
Online ISBN: 978-1-59259-841-0
eBook Packages: MedicineMedicine (R0)